Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2020

01-11-2020 | Prediabetes | Original Research

Psychometric Properties of the Altarum Consumer Engagement (ACE) Measure of Activation in Patients with Prediabetes

Authors: Yelba Castellon-Lopez, MD, MS, Kia Skrine Jeffers, PhD, RN, O. Kenrik Duru, MD, MS, Gerardo Moreno, MD, MS, Tannaz Moin, MD, MBA, MS, Jonathan Grotts, MA, Carol M. Mangione, MD, MPH, Keith C. Norris, MD, PhD, Ron D. Hays, PhD

Published in: Journal of General Internal Medicine | Issue 11/2020

Login to get access

Abstract

Background

Patient activation is associated with better outcomes in chronic conditions.

Objective

We evaluated the psychometric properties of the 12-item Altarum Consumer Engagement™ Measure (ACE-12) in patients with prediabetes.

Participants

ACE-12 was administered to patients in the Prediabetes Informed Decisions and Education Study.

Main Measures

We conducted an exploratory factor analysis followed by confirmatory factor analytic models. We evaluated item response categories using item characteristic curves. Construct validity was assessed by examining correlations of the ACE-12 scales with education, depressive symptoms, self-rated health, hemoglobin A1c, body mass index, and weight loss.

Key Results

Participants (n = 515) had a median age of 58; 56% were female; 17% Hispanic; 54% were non-White. The scree plot and Tucker and Lewis reliability coefficient (0.95) suggested three factors similar to the original scales. One item loaded on the navigation rather than the informed choice scale. Ordinal alpha coefficients for the original scales were commitment (0.75); informed choice (0.71); and navigation (0.54). ICCs indicated that one or more of the response categories for 5 of the 12 items were never most likely to be selected.
Patients with lower education were less activated on the commitment (r = − 0.124, p = 0.004), choice (r = − 0.085, p = 0.009), and overall score (r = − 0.042, p = 0.011). Patients with depressive symptoms had lower commitment (r = − 0.313, p ≤ 0.001) and overall scores (r = − 0.172, p = 0.012). Patients with poorer health scored lower on the Commitment (r = − 0.308, p ≤ 0.001), Navigation (r = − 0.137, p ≤ 0.001), and overall score (r = − 0.279, p ≤ 0.001).

Conclusion

The analyses provide some support for the psychometric properties of the ACE-12 in prediabetic patients. Future research evaluating this tool among patients with other chronic conditions are needed to determine whether Q1 (I spend a lot of time learning about health) should remain in the informed choice or be included in the navigation scale. Additional items may be needed to yield acceptable reliability for the navigation scale.
Literature
2.
go back to reference Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine. 2002;346(6):393–403.CrossRef Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England journal of medicine. 2002;346(6):393–403.CrossRef
3.
go back to reference Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. The lancet Diabetes & endocrinology. 2015;3(11):866–875. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. The lancet Diabetes & endocrinology. 2015;3(11):866–875.
4.
go back to reference Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009;374(9702):1677–1686.CrossRef Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009;374(9702):1677–1686.CrossRef
5.
go back to reference Rodriguez HP, Poon BY, Wang E, Shortell SM. Linking Practice Adoption of Patient Engagement Strategies and Relational Coordination to Patient-Reported Outcomes in Accountable Care Organizations. Milbank Q. 2019. Rodriguez HP, Poon BY, Wang E, Shortell SM. Linking Practice Adoption of Patient Engagement Strategies and Relational Coordination to Patient-Reported Outcomes in Accountable Care Organizations. Milbank Q. 2019.
6.
go back to reference Hibbard J, Cunningham P. How engaged are consumers in thier health and health care, and why does it matter? Res Briefs. 2008;8:1–9. Hibbard J, Cunningham P. How engaged are consumers in thier health and health care, and why does it matter? Res Briefs. 2008;8:1–9.
7.
go back to reference Zimbudzi E, Lo C, Ranasinha S, et al. The association between patient activation and self-care practices: A cross-sectional study of an Australian population with comorbid diabetes and chronic kidney disease. Health Expect. 2017;20(6):1375–1384.CrossRef Zimbudzi E, Lo C, Ranasinha S, et al. The association between patient activation and self-care practices: A cross-sectional study of an Australian population with comorbid diabetes and chronic kidney disease. Health Expect. 2017;20(6):1375–1384.CrossRef
8.
go back to reference Lubetkin EI, Lu WH, Gold MR. Levels and correlates of patient activation in health center settings: building strategies for improving health outcomes. J Health Care Poor Underserved. 2010;21(3):796–808.CrossRef Lubetkin EI, Lu WH, Gold MR. Levels and correlates of patient activation in health center settings: building strategies for improving health outcomes. J Health Care Poor Underserved. 2010;21(3):796–808.CrossRef
9.
go back to reference Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage. 2007;30(1):21–29.CrossRef Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage. 2007;30(1):21–29.CrossRef
10.
go back to reference Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42(4):1443–1463.CrossRef Hibbard JH, Mahoney ER, Stock R, Tusler M. Do increases in patient activation result in improved self-management behaviors? Health Serv Res. 2007;42(4):1443–1463.CrossRef
11.
go back to reference Shively MJ, Gardetto NJ, Kodiath MF, et al. Effect of patient activation on self-management in patients with heart failure. J Cardiovasc Nurs. 2013;28(1):20–34.CrossRef Shively MJ, Gardetto NJ, Kodiath MF, et al. Effect of patient activation on self-management in patients with heart failure. J Cardiovasc Nurs. 2013;28(1):20–34.CrossRef
12.
go back to reference Yadav UN, Hosseinzadeh H, Lloyd J, Harris MF. How health literacy and patient activation play their own unique role in self-management of chronic obstructive pulmonary disease (COPD)? Chronic respiratory disease. 2019;16:1479973118816418.CrossRef Yadav UN, Hosseinzadeh H, Lloyd J, Harris MF. How health literacy and patient activation play their own unique role in self-management of chronic obstructive pulmonary disease (COPD)? Chronic respiratory disease. 2019;16:1479973118816418.CrossRef
13.
go back to reference Mayberry R, Willock RJ, Boone L, Lopez P, Qin H, Nicewander D. A High Level of Patient Activation Is Observed But Unrelated to Glycemic Control Among Adults With Type 2 Diabetes. Diabetes Spectr. 2010;23(3):171–176.CrossRef Mayberry R, Willock RJ, Boone L, Lopez P, Qin H, Nicewander D. A High Level of Patient Activation Is Observed But Unrelated to Glycemic Control Among Adults With Type 2 Diabetes. Diabetes Spectr. 2010;23(3):171–176.CrossRef
14.
go back to reference Marshall R, Beach MC, Saha S, et al. Patient activation and improved outcomes in HIV-infected patients. J Gen Intern Med. 2013;28(5):668–674.CrossRef Marshall R, Beach MC, Saha S, et al. Patient activation and improved outcomes in HIV-infected patients. J Gen Intern Med. 2013;28(5):668–674.CrossRef
15.
go back to reference Duke CC, Lynch WD, Smith B, Winstanley J. Validity of a New Patient Engagement Measure: The Altarum Consumer Engagement (ACE) Measure. Patient. 2015;8(6):559–568.CrossRef Duke CC, Lynch WD, Smith B, Winstanley J. Validity of a New Patient Engagement Measure: The Altarum Consumer Engagement (ACE) Measure. Patient. 2015;8(6):559–568.CrossRef
16.
go back to reference Wardian J, Bersabe D, Duke C, Sauerwein TJ. Patient Commitment and Its Relationship to A1C. Clinical diabetes : a publication of the American Diabetes Association. 2018;36(4):295–304.CrossRef Wardian J, Bersabe D, Duke C, Sauerwein TJ. Patient Commitment and Its Relationship to A1C. Clinical diabetes : a publication of the American Diabetes Association. 2018;36(4):295–304.CrossRef
17.
go back to reference Moin T, Duru OK, Turk N, et al. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial. J Gen Intern Med. 2019;34(11):2652–2659.CrossRef Moin T, Duru OK, Turk N, et al. Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial. J Gen Intern Med. 2019;34(11):2652–2659.CrossRef
18.
go back to reference Skrine Jeffers K, Castellon-Lopez Y, Grotts J, et al. Diabetes Prevention Program attendance is associated with improved patient activation: Results from the Prediabetes Informed Decisions and Education (PRIDE) study. Prev Med Rep. 2019;16:100961.CrossRef Skrine Jeffers K, Castellon-Lopez Y, Grotts J, et al. Diabetes Prevention Program attendance is associated with improved patient activation: Results from the Prediabetes Informed Decisions and Education (PRIDE) study. Prev Med Rep. 2019;16:100961.CrossRef
19.
go back to reference Hu L, Bentler, PM. Cutofff criteria for fit indicies in covariance analysis: conventional criteria versus new alternatives. Struc Equation Modeling. 1999(6 (1)):1–55.CrossRef Hu L, Bentler, PM. Cutofff criteria for fit indicies in covariance analysis: conventional criteria versus new alternatives. Struc Equation Modeling. 1999(6 (1)):1–55.CrossRef
20.
go back to reference Samejima F. The graded response model. In: Handbook of modern item response theor. New York, NY: Springer; 1996. Samejima F. The graded response model. In: Handbook of modern item response theor. New York, NY: Springer; 1996.
21.
go back to reference Magnezi R, Glasser S, Shalev H, Sheiber A, Reuveni H. Patient activation, depression and quality of life. Patient Educ Couns. 2014;94(3):432–437.CrossRef Magnezi R, Glasser S, Shalev H, Sheiber A, Reuveni H. Patient activation, depression and quality of life. Patient Educ Couns. 2014;94(3):432–437.CrossRef
22.
go back to reference Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27(5):520–526.CrossRef Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27(5):520–526.CrossRef
23.
go back to reference Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1988. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Academic Press; 1988.
24.
go back to reference Muthén L, Muthén BO. Mplus user's guide. 7th ed. Los Angeles, CA: Muthén & Muthén; 2012. Muthén L, Muthén BO. Mplus user's guide. 7th ed. Los Angeles, CA: Muthén & Muthén; 2012.
26.
go back to reference Ely EK, Gruss SM, Luman ET, et al. A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program. Diabetes Care. 2017;40(10):1331–1341.CrossRef Ely EK, Gruss SM, Luman ET, et al. A National Effort to Prevent Type 2 Diabetes: Participant-Level Evaluation of CDC's National Diabetes Prevention Program. Diabetes Care. 2017;40(10):1331–1341.CrossRef
27.
go back to reference Swardfager W, Yang P, Herrmann N, et al. Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes. Diabet Med. 2016;33(4):529–536.CrossRef Swardfager W, Yang P, Herrmann N, et al. Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes. Diabet Med. 2016;33(4):529–536.CrossRef
28.
go back to reference Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–2403.CrossRef Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–2403.CrossRef
29.
go back to reference Katz LL, Anderson BJ, McKay SV, et al. Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes. Diabetes Care. 2016;39(11):1956–1962.CrossRef Katz LL, Anderson BJ, McKay SV, et al. Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes. Diabetes Care. 2016;39(11):1956–1962.CrossRef
30.
go back to reference Feng L, Yap KB, Ng TP. Depressive symptoms in older adults with chronic kidney disease: mortality, quality of life outcomes, and correlates. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2013;21(6):570–579.CrossRef Feng L, Yap KB, Ng TP. Depressive symptoms in older adults with chronic kidney disease: mortality, quality of life outcomes, and correlates. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2013;21(6):570–579.CrossRef
31.
go back to reference Lin EHB, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154–2160.CrossRef Lin EHB, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27(9):2154–2160.CrossRef
32.
go back to reference van Vugt HA, Boels AM, de Weerdt I, de Koning EJ, Rutten GE. Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin. Patient preference and adherence. 2019;13:73–81.CrossRef van Vugt HA, Boels AM, de Weerdt I, de Koning EJ, Rutten GE. Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin. Patient preference and adherence. 2019;13:73–81.CrossRef
Metadata
Title
Psychometric Properties of the Altarum Consumer Engagement (ACE) Measure of Activation in Patients with Prediabetes
Authors
Yelba Castellon-Lopez, MD, MS
Kia Skrine Jeffers, PhD, RN
O. Kenrik Duru, MD, MS
Gerardo Moreno, MD, MS
Tannaz Moin, MD, MBA, MS
Jonathan Grotts, MA
Carol M. Mangione, MD, MPH
Keith C. Norris, MD, PhD
Ron D. Hays, PhD
Publication date
01-11-2020
Publisher
Springer International Publishing
Keyword
Prediabetes
Published in
Journal of General Internal Medicine / Issue 11/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05727-z

Other articles of this Issue 11/2020

Journal of General Internal Medicine 11/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.